Sumitomo Dainippon Pharma competitive analysis

Explore Sumitomo Dainippon Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 13, 2016Rat Embryonic Stem Cell1

Latest PTAB cases involving Sumitomo Dainippon Pharma

Discover the latest PTAB cases involving Sumitomo Dainippon Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 1, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sumitomo Dainippon Pharma

IPR2020-01053Jun 5, 2020SLAYBACK PHARMASUMITOMO DAINIPPON PHARMATerminated
IPR2017-01292Apr 18, 2017PAR PHARMACEUTICALSUMITOMO DAINIPPON PHARMATerminated-Settled

Peer Comparison New

IP litigation analysis comparing Sumitomo Dainippon Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SUMITOMO DAINIPPON PHARMA - 1 - 2
PAR PHARMACEUTICAL - - 21 -
SCHLICH43 - - -
SLAYBACK PHARMA - - 3 -